These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27471760)

  • 1. CardioPulse: Cyclosporine to reduce myocardial infarction injury?
    Nicholls M
    Eur Heart J; 2016 Jan; 37(3):210-1. PubMed ID: 27471760
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: A meta-analysis.
    Upadhaya S; Madala S; Baniya R; Subedi SK; Saginala K; Bachuwa G
    Cardiol J; 2017; 24(1):43-50. PubMed ID: 27734457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine in acute myocardial infarction.
    Ibanez B; Badimon JJ
    N Engl J Med; 2008 Nov; 359(21):2287; author reply 2288-9. PubMed ID: 19031538
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine in acute myocardial infarction.
    Ryding AD
    N Engl J Med; 2008 Nov; 359(21):2287-8; author reply 2288-9. PubMed ID: 19031540
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine in acute myocardial infarction.
    Hoffman I
    N Engl J Med; 2008 Nov; 359(21):2287; author reply 2288-9. PubMed ID: 19031539
    [No Abstract]   [Full Text] [Related]  

  • 6. Time to take myocardial reperfusion injury seriously.
    Hausenloy DJ; Yellon DM
    N Engl J Med; 2008 Jul; 359(5):518-20. PubMed ID: 18669431
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving the outcome of primary PCI: protection from reperfusion injury.
    Heusch G
    Cardiovasc Res; 2017 Aug; 113(10):e33-e34. PubMed ID: 28899004
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closing the pore on reperfusion injury: myocardial protection with cyclosporine.
    Muehlschlegel JD
    Anesthesiology; 2014 Aug; 121(2):212-3. PubMed ID: 24895914
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of permeability transition and myocardic reperfusion damage by cyclosporine A].
    Chávez E; García N; Pavón N
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-77-81. PubMed ID: 18938702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine protects the heart during aortic valve surgery.
    Chiari P; Angoulvant D; Mewton N; Desebbe O; Obadia JF; Robin J; Farhat F; Jegaden O; Bastien O; Lehot JJ; Ovize M
    Anesthesiology; 2014 Aug; 121(2):232-8. PubMed ID: 25050491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-conditioning with cyclosporine A fails to reduce the infarct size in an in vivo porcine model.
    Lie RH; Stoettrup N; Sloth E; Hasenkam JM; Kroyer R; Nielsen TT
    Acta Anaesthesiol Scand; 2010 Aug; 54(7):804-13. PubMed ID: 20455870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
    J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in acute myocardial infarction.
    Theruvath TP; Lemasters JJ
    N Engl J Med; 2008 Nov; 359(21):2286; author reply 2288-9. PubMed ID: 19020331
    [No Abstract]   [Full Text] [Related]  

  • 16. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.
    Nakamura Y; Yamada Y; Shimomura H; Nagayoshi Y; Tsujita K; Yamashita T; Fukuda M; Ohba K; Nako H; Ogura Y; Chitose T; Yamaguchi M; Nagata T; Soejima H; Kaikita K; Sugiyama S; Ogawa H
    J Cardiol; 2009 Dec; 54(3):416-24. PubMed ID: 19944317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
    Shavadia J; Zheng Y; Dianati Maleki N; Huber K; Halvorsen S; Goldstein P; Gershlick AH; Wilcox R; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2015 Aug; 4(8):e002049. PubMed ID: 26304934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The giant leap and small steps to better reperfusion in ST-segment elevation myocardial infarction patients.
    Brekke M
    Cardiology; 2013; 124(4):216-8. PubMed ID: 23548811
    [No Abstract]   [Full Text] [Related]  

  • 20. CIRCUS: a kiss of death for cardioprotection?
    Heusch G
    Cardiovasc Res; 2015 Nov; 108(2):215-6. PubMed ID: 26410370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.